These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pathophysiology of experimental nephrotic syndrome induced by puromycin aminonucleoside in rats. I. The role of proteinuria, hypoproteinemia, and renin-angiotensin-aldosterone system on sodium retention. Pedraza-Chaverrí J, Cruz C, Ibarra-Rubio ME, Chávez MT, Calleja C, Tapia E, del Carmen Uribe M, Romero L, Peña JC. Rev Invest Clin; 1990; 42(1):29-38. PubMed ID: 2236972 [Abstract] [Full Text] [Related]
11. Blunted renal dopaminergic system activity in puromycin aminonucleoside-induced nephrotic syndrome. Sampaio-Maia B, Moreira-Rodrigues M, Serrão P, Pestana M. Nephrol Dial Transplant; 2006 Feb; 21(2):314-23. PubMed ID: 16204272 [Abstract] [Full Text] [Related]
12. [Cellular and molecular mechanisms of sodium pump activation in experimental models of nephrotic syndrome]. Deschênes G, Feraille E, Doucet A. Nephrologie; 2003 Feb; 24(3):121-6. PubMed ID: 12814058 [Abstract] [Full Text] [Related]
13. A study of the renin-angiotensin system and the blood volume in the nephrotic syndrome. Yoo HD, Choi KS, Jung MH, Lee WS, Lee JW, Lee SR, Kim JS, Cho WK. Korean J Intern Med; 1986 Jan; 1(1):72-7. PubMed ID: 15759380 [Abstract] [Full Text] [Related]
15. A critique of the overfill hypothesis of sodium and water retention in the nephrotic syndrome. Schrier RW, Fassett RG. Kidney Int; 1998 May; 53(5):1111-7. PubMed ID: 9573524 [Abstract] [Full Text] [Related]